Nabsys Appoints Anthony Shuber as Chief Scientific Officer

29-Oct-2014 - USA

Nabsys, Inc. announced today Anthony Shuber has joined the company as Vice President and Chief Scientific Officer. In this role, Shuber will lead the company’s efforts in product strategy as the company transitions its initial commercial focus toward oncology.

Shuber, an industry veteran and accomplished inventor, has over 24 years of experience in developing commercial diagnostics and research and applied genomics products and holds 50 patents. Shuber joins Nabsys from Ignyta, Inc., an oncology precision medicine biotechnology company, where he served as Chief Technology Officer and Vice President. Prior to joining Ignyta, Shuber was Co-Founder and Chief Technology Officer of Predictive Biosciences, Inc., as well as scientific Co-Founder of Exact Sciences, where he led both companies’ general scientific and applied research efforts. He also has experience at Genzyme Genetics / Integrated Genetics and Genetics Institute. Shuber was awarded the Colorectal Cancer Network’s first annual 90 in 9 Science Award and holds a B.S. and M.S. degree in Biology from Marquette University.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances